Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to characterize the pharmacokinetics of multi-dose RVX000222 and
atorvastatin and rosuvastatin when either statin is administered in combination with
RVX000222 in subjects with dyslipidemia.
Phase:
Phase 2
Details
Lead Sponsor:
Resverlogix Corp
Collaborator:
South Australian Health and Medical Research Institute